Posted by Michael Wonder on 24 Feb 2024
Prices for new US drugs rose 35% in 2023, more than the previous year
23 February 2024 - Pharmaceutical companies last year launched new US drugs at prices 35% higher than in 2022, reflecting in part the industry's embrace of expensive therapies for rare diseases like muscular dystrophy, a Reuters analysis found.
The median annual list price for a new drug was $300,000 in 2023, according to the Reuters analysis of 47 medicines, up from $222,000 a year earlier. In 2021, the median annual price was $180,000, opens new tab for the 30 drugs first marketed through mid-July, according to a study published in JAMA.
